Inventor
ELMORE STEVEN W
US47 patents
⚠️ This page may combine multiple inventors who share the name “ELMORE STEVEN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
17 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9045475B2Jun 2, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC14 citations93
US9315488B2Apr 19, 2016
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC13 citations92
US9029404B2May 12, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations92
US8952157B2Feb 10, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC22 citations91
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9073855B2Jul 7, 2015
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045420B2Jun 2, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9034875B2May 19, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations84
US9493411B2Nov 15, 2016
Pyrrole-3-carboxamide bromodomain inhibitors
ABBVIE INC3 citations72
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9493431B2Nov 15, 2016
Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9359296B2Jun 7, 2016
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9156856B2Oct 13, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9035047B2May 19, 2015
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
ABBOTT LAB
16 patentsUS7390799B2Jun 24, 2008
Apoptosis promoters
ABBOTT LAB331 citations98
US7709467B2May 4, 2010
Apoptosis promoters
ABBOTT LAB50 citations97
US6506766B1Jan 14, 2003
Glucocortiocoid-selective antinflammatory agents
ABBOTT LAB74 citations95
US7585858B2Sep 8, 2009
N-sulfonylcarboximidamide apoptosis promoters
ABBOTT LAB19 citations93
US7449485B2Nov 11, 2008
N-sulfonylurea apoptosis promoters
ABBOTT LAB19 citations93
US7358251B2Apr 15, 2008
N-sulfonylurea apoptosis promoters
ABBOTT LAB19 citations93
US7030115B2Apr 18, 2006
N-sulfonylurea apoptosis promoters
ABBOTT LAB32 citations93
US8343967B2Jan 1, 2013
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBOTT LAB32 citations92
US7906505B2Mar 15, 2011
Apoptosis promoters
ABBOTT LAB18 citations92
US7842681B2Nov 30, 2010
Treatment of myeoproliferative diseases
ABBOTT LAB51 citations92
US5597823AJan 28, 1997
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
ABBOTT LAB31 citations92
US7981888B2Jul 19, 2011
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
ABBOTT LAB8 citations84
US7910742B2Mar 22, 2011
Survivin inhibitors
ABBOTT LAB9 citations82
US7777076B2Aug 17, 2010
Macrocyclic inhibitors of BCL proteins
ABBOTT LAB6 citations63
US7989656B2Aug 2, 2011
Biaryl carboxylic acid apoptosis promoters
ABBOTT LAB0 citations51
US7750004B2Jul 6, 2010
Apoptosis promoters
ABBOTT LAB0 citations51
BRUNCKO MILAN
3 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97